Lynparza extends progressionfree survival in gBRCAm metastatic pancreatic cancer httpbit.ly2EyIHla cancer pharma AstraZeneca MSDInvents Merck oncology

Lynparza extends progression-free survival in gBRCAm metastatic pancreatic #cancer http://bit.ly/2EyIHla  #cancer #pharma @AstraZeneca @MSDInvents @Merck #oncology

13:00 EST 26 Feb 2019 | Pharmafile

Lynparza extends progression-free survival in gBRCAm metastatic pancreatic #cancer http://bit.ly/2EyIHla  #cancer #pharma @AstraZeneca @MSDInvents @Merck #oncology

More From BioPortfolio on "Lynparza extends progression-free survival in gBRCAm metastatic pancreatic #cancer http://bit.ly/2EyIHla  #cancer #pharma @AstraZeneca @MSDInvents @Merck #oncology"